Shortt reports: the view from Ophthalmology Futures Forum 2016
Fight for Sight researcher Dr Alex Shortt's quick video summaries of the meeting between industry and top clinicians on the future of treatments for the eye and sight loss.
There was a morning session on age-related macular degeneration and whether the drug treatment 'pipeline' has run dry. Alex doesn't think so.
Then we heard about the challenges for big pharma in developing gene therapy. Alex has a suggestion.
Before lunch Alex started sounding pretty excited about a new development for clearing fluid from the cornea.
Alex chaired the afternoon session on dry eye. Big changes coming, he says.
Finally, Alex wound up the day with a report on the glaucoma session. He has seen something he thinks may become the future of glaucoma treatment.
Big thanks to Alex for being our reporter in the field for the day. There are some great possibilities in there. Now we need to see them in the clinic!